Researchers from UC San Francisco, have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver.
SPORE Grant from National Cancer Institute provides resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes.
From curing Alzheimer’s to preventing cancer and pneumonia, UCSF postdoctoral scholars tackle complex medical conditions at annual Postdoc Slam competition.
UCSF-led study examined more than 800 children with acute lymphoblastic leukemia (ALL), looking at how pesticide exposure affected five-year survival rates.
The first FDA-approved antibody-drug conjugate therapy for metastatic UC (mUC), enfortumab vedotin (EV), targets NECTIN4, a protein that is expressed on the cell surface of bladder cancer cells, and is now the frontline, standard of care treatment for patients with advanced urothelial carcinoma in the U.S.
Led by Andrei Goga, MD, PhD, a team of scientists caught cancer cells in the act of breaking into fat cells. The energy heist seems to be critical for the growth of deadly breast cancer.
Matching grant from Weill family creates collaborative research hub, uniting scientists from UCSF and Stanford Medicine to transform cancer care within a decade.